Abeona Therapeutics Inc (ABEO) stock forecast · rev $20.1M
Abeona Therapeutics Inc (ABEO) is a biotechnology company listed on US.
This ABEO forecast page states what the cached financials imply — not a price target and not a guarantee. Abeona Therapeutics Inc outlooks on Lician start from reported revenue and the latest filing, then you decide.
Latest reported ABEO revenue for 2026-06-30 was $20.1M. Net income was -$37.3M. ABEO currently screens at market cap $301.8M.
Period-over-period revenue change is not in cache for ABEO, so this page does not invent a growth rate.
ABEO currently screens at market cap $301.8M. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next ABEO 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the ABEO stock page.
Not investment advice.